CAPPED BONUS-ZERTIFIKAT - TEVA PHARMACEUTICAL INDUSTRIES Stock

Certificat

DE000KJ32QA4

Market Closed - Deutsche Boerse AG 01:29:18 2024-05-30 pm EDT
11.57 EUR -0.17% Intraday chart for CAPPED BONUS-ZERTIFIKAT - TEVA PHARMACEUTICAL INDUSTRIES
3 months+5.95%
Current year+24.27%
Date Price Change
24-05-30 11.57 -0.17%
24-05-29 11.59 +0.52%
24-05-28 11.53 +0.09%
24-05-27 11.52 -.--%
24-05-24 11.52 -0.43%

Delayed Quote Deutsche Boerse AG

Last update May 30, 2024 at 01:29 pm EDT

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying TEVA PHARMACEUTICAL INDUSTRIES LIMITED
IssuerLogo Issuer Citi Citi
WKN KJ32QA
ISINDE000KJ32QA4
Date issued 2023-12-27
Strike 13 $
Maturity 2024-12-19 (201 Days)
Parity 1 : 1
Emission price 9.52
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 11.61
Lowest since issue 9.28

Company Profile

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Sector
-
More about the company

Ratings for Teva Pharmaceutical Industries Limited

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Teva Pharmaceutical Industries Limited

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
16.93 USD
Average target price
17.84 USD
Spread / Average Target
+5.35%
Consensus